Dr Charles J Bell And Associates Optometrist Medicare: Medicare Enrolled Practice Location: 302 N Elm St, Tuskegee, AL 36083 Phone: 334-727-6247 |
Dr. Robert Boyd Lewis Iv, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2400 Hospital Road (115-s), Cavhcs Eye Clinic, Tuskegee, AL 36083 Phone: 334-727-0550 Fax: 334-724-6812 |
Jordan Daniel Rockwell, O.D. Optometrist - Corneal and Contact Management Medicare: Medicare Enrolled Practice Location: 2400 Hospital Rd, Tuskegee, AL 36083 Phone: 343-724-0550 |
Dr. Charles Jerome Bell, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 302 N Elm St, Tuskegee, AL 36083 Phone: 334-727-6247 Fax: 334-725-1600 |
News Archive
In an analysis from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, one of the largest studies of its kind to determine whether intensive blood glucose (sugar) control worked better than standard blood sugar control among diabetics, results show that the benefits of intensive therapy need to be balanced against the increase in total and cardiovascular disease-related death, increased weight gain, and high risk for severe low blood sugar.
A research team led by scientists at the Columbia University Mailman School of Public Health report on a new method to help health officials control outbreaks of methicillin-resistant Staphylococcus aureus, or MRSA, a life-threatening antibiotic-resistant infection often seen in hospitals.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it has priced an underwritten public offering of 39,200,000 shares of common stock and warrants to purchase up to 39,200,000 shares of common stock at a combined public offering price of $0.52 per share and related warrant for gross proceeds of approximately $20.4 million.
The Premier healthcare alliance today announced that Bon Secours St. Francis Medical Center of Midlothian, Va., selected Premier's SafetySurveillor® Web-based infection tracking and antimicrobial utilization tool. More than 270 hospitals use SafetySurveillor to help prevent healthcare-associated infections (HAIs) and optimize antibiotic use, thereby protecting patients more effectively while safely reducing hospital costs.
AstraZeneca Canada Inc. announced today that Health Canada has approved FluMist (Influenza Vaccine, Live, Attenuated) for the prevention of seasonal influenza. FluMist is the first vaccine in Canada that is administered as a gentle mist sprayed into the nose.
› Verified 8 days ago